Gamma Knife surgery for hypothalamic hamartomas and epilepsy: patient selection and outcomes

Clinical article

Restricted access

Object

The authors present outcomes obtained in patients who underwent Gamma Knife surgery (GKS) at 1 institution as part of a multimodal treatment of refractory epilepsy caused by hypothalamic hamartomas (HHs).

Methods

Between 2003 and 2010, 19 patients with HH underwent GKS. Eight patients had follow-up for less than 1 year, and 1 patient was lost to follow-up. The 10 remaining patients (mean age 15.1 years, range 5.7–29.3 years) had a mean follow-up of 43 months (range 18–81 months) and are the focus of this report. Five patients had undergone a total of 6 prior surgeries: 1 transcallosal resection of the HH, 2 endoscopic transventricular resections of the HH, 2 temporal lobectomies, and 1 arachnoid cyst evacuation. In an institutional review board–approved study, postoperative complications and long-term outcome measures were monitored prospectively with the use of a proprietary database. Seven patients harbored Delalande Type II lesions; the remainder harbored Type III or IV lesions. Seizure frequency ranged from 1–2 monthly to as many as 100 gelastic seizures daily. The mean lesion volume was 695 mm3 (range 169–3000 mm3, median 265 mm3). The mean/median dose directed to the 50% isodose line was 18 Gy (range 16–20 Gy). The mean maximum point dose to the optic chiasm was 7.5 Gy (range 5–10 Gy). Three patients underwent additional resection 14.5, 21, and 32 months after GKS.

Results

Of the 10 patients included in this study, 6 are seizure free (2 after they underwent additional surgery), 1 has a 50%–90% reduction in seizure frequency, 2 have a 50% reduction in seizure frequency, and 1 has observed no change in seizure frequency. Overall quality of life, based on data obtained from follow-up telephone conversations and/or surveys, improved in 9 patients and was due to improvements in seizure control (9 patients), short-term memory loss (3 patients), and behavioral symptoms (5 patients); in 1 patient, quality of life remains minimally affected. Incidences of morbidity were all temporary and included poikilothermia (1 patient), increased depression (1 patient), weight gain/increased appetite (2 patients), and anxiety (1 patient) after GKS.

Conclusions

Of the approximately 150 patients at Barrow Neurological Institute who have undergone treatment for HH, the authors have reserved GKS for treatment of small HHs located distal from radiosensitive structures in patients with high cognitive function and a stable clinical picture, which allows time for the effects of radiosurgery to occur without further deterioration. The lack of significant morbidity and the clinical outcomes achieved in this study demonstrated a low risk of GKS for HH with results comparable to those of previous series.

Abbreviations used in this paper: AED = antiepileptic drug; GKS = Gamma Knife surgery; HH = hypothalamic hamartoma.

Article Information

Address correspondence to: Adib A. Abla, M.D., Barrow Neurological Institute, 350 West Thomas Road, Phoenix, Arizona 85013. email: adib.abla@gmail.com.

© AANS, except where prohibited by US copyright law.

Headings

Figures

  • View in gallery

    Pie charts showing seizure control and outcomes for secondary end points (behavior and cognition) after GKS in 10 patients.

  • View in gallery

    Bar graph showing seizure control stratified by type of HH treated by GKS.

References

  • 1

    Abla AARekate HLWilson DAWait SDUschold TPrenger E: Orbitozygomatic resection for hypothalamic hamartoma and epilepsy: patient selection and outcome. Childs Nerv Syst [epub ahead of print]2010

  • 2

    Arita KKurisu KIida KHanaya RAkimitsu THibino S: Subsidence of seizure induced by stereotactic radiation in a patient with hypothalamic hamartoma. Case report. J Neurosurg 89:6456481998

  • 3

    Barajas MARamírez-Guzman MGRodríguez-Vázquez CToledo-Buenrostro VCuevas-Solórzano ARodríguez-Hernández G: Gamma knife surgery for hypothalamic hamartomas accompanied by medically intractable epilepsy and precocious puberty: experience in Mexico. J Neurosurg 102:Suppl53552005

  • 4

    Delalande OFohlen M: Disconnecting surgical treatment of hypothalamic hamartoma in children and adults with refractory epilepsy and proposal of a new classification. Neurol Med Chir (Tokyo) 43:61682003

  • 5

    Dunoyer CRagheb JResnick TAlvarez LJayakar PAltman N: The use of stereotactic radiosurgery to treat intractable childhood partial epilepsy. Epilepsia 43:2923002002

  • 6

    Engel JVan Ness PCRasmussen TBOutcome with respect to epileptic seizures. Engel J: Surgical Treatment of the Epilepsies ed 2New YorkRaven Press1993. 609621

  • 7

    Frazier JLGoodwin CRAhn ESJallo GI: A review on the management of epilepsy associated with hypothalamic hamartomas. Childs Nerv Syst 25:4234322009

  • 8

    Likavec AMDickerman RDHeiss JDLiow K: Retrospective analysis of surgical treatment outcomes for gelastic seizures: a review of the literature. Seizure 9:2042072000

  • 9

    Mathieu DKondziolka DNiranjan AFlickinger JLunsford LD: Gamma knife radiosurgery for refractory epilepsy caused by hypothalamic hamartomas. Stereotact Funct Neurosurg 84:82872006

  • 10

    Ng YTRekate HLPrenger ECChung SSFeiz-Erfan IWang NC: Transcallosal resection of hypothalamic hamartoma for intractable epilepsy. Epilepsia 47:119212022006

  • 11

    Ng YTRekate HLPrenger ECWang NCChung SSFeiz-Erfan I: Endoscopic resection of hypothalamic hamartomas for refractory symptomatic epilepsy. Neurology 70:154315482008

  • 12

    Palmini APaglioli-Neto EMontes JFarmer JP: The treatment of patients with hypothalamic hamartomas, epilepsy and behavioural abnormalities: facts and hypotheses. Epileptic Disord 5:2492552003

  • 13

    Régis JBartolomei Fde Toffol BGenton PKobayashi TMori Y: Gamma knife surgery for epilepsy related to hypothalamic hamartomas. Neurosurgery 47:134313522000

  • 14

    Régis JHayashi MEupierre LPVilleneuve NBartolomei FBrue T: Gamma knife surgery for epilepsy related to hypothalamic hamartomas. Acta Neurochir Suppl (Wien) 91:33502004

  • 15

    Régis JScavarda DTamura MNagayi MVilleneuve NBartolomei F: Epilepsy related to hypothalamic hamartomas: surgical management with special reference to gamma knife surgery. Childs Nerv Syst 22:8818952006

  • 16

    Régis JScavarda DTamura MVilleneuve NBartolomei FBrue T: Gamma knife surgery for epilepsy related to hypothalamic hamartomas. Semin Pediatr Neurol 14:73792007

  • 17

    Rowe JGrainger AWalton LSilcocks PRadatz MKemeny A: Risk of malignancy after gamma knife stereotactic radiosurgery. Neurosurgery 60:60662007

  • 18

    Unger FSchröttner OFeichtinger MBone GHaselsberger KSutter B: Stereotactic radiosurgery for hypothalamic hamartomas. Acta Neurochir Suppl (Wien) 84:57632002

TrendMD

Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 77 77 13
Full Text Views 130 130 1
PDF Downloads 98 98 1
EPUB Downloads 0 0 0

PubMed

Google Scholar